Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 66 entries
Sorted by: Best Match Show Resources per page
Ischemic Neuromyopathy Associated with Steel Pellet BB Shot Aortic Obstruction in a Cat.

The Canadian veterinary journal = La revue veterinaire canadienne

Langelier KM.
PMID: 17422151
Can Vet J. 1982 Jun;23(6):187-9.

An adult female calico cat was presented with clinical signs of posterior paresis. A steel pellet was seen radiographically lodged in the caudal aorta ventral to the fourth lumbar vertebra. Aortotomy was performed and the pellet was removed. Due...

Cite
Langelier KM. Ischemic Neuromyopathy Associated with Steel Pellet BB Shot Aortic Obstruction in a Cat. Can Vet J. 1982;23(6):187-9
Langelier, K. M. (1982). Ischemic Neuromyopathy Associated with Steel Pellet BB Shot Aortic Obstruction in a Cat. The Canadian veterinary journal = La revue veterinaire canadienne, 23(6), 187-9.
Langelier, K M. "Ischemic Neuromyopathy Associated with Steel Pellet BB Shot Aortic Obstruction in a Cat." The Canadian veterinary journal = La revue veterinaire canadienne vol. 23,6 (1982): 187-9.
Langelier KM. Ischemic Neuromyopathy Associated with Steel Pellet BB Shot Aortic Obstruction in a Cat. Can Vet J. 1982 Jun;23(6):187-9. PMID: 17422151; PMCID: PMC1790164.
Copy Download .nbib Format: NLM
Lead poisoning in bald eagles in British Columbia.

The Canadian veterinary journal = La revue veterinaire canadienne

Langelier KM, Andress CE, Grey TK, Wooldridge C, Lewis RJ, Marchetti R.
PMID: 17423732
Can Vet J. 1991 Feb;32(2):108-9.

No abstract available.

Cite
Langelier KM, Andress CE, Grey TK, et al. Lead poisoning in bald eagles in British Columbia. Can Vet J. 1991;32(2):108-9
Langelier, K. M., Andress, C. E., Grey, T. K., Wooldridge, C., Lewis, R. J., & Marchetti, R. (1991). Lead poisoning in bald eagles in British Columbia. The Canadian veterinary journal = La revue veterinaire canadienne, 32(2), 108-9.
Langelier, K M, et al. "Lead poisoning in bald eagles in British Columbia." The Canadian veterinary journal = La revue veterinaire canadienne vol. 32,2 (1991): 108-9.
Langelier KM, Andress CE, Grey TK, Wooldridge C, Lewis RJ, Marchetti R. Lead poisoning in bald eagles in British Columbia. Can Vet J. 1991 Feb;32(2):108-9. PMID: 17423732; PMCID: PMC1480957.
Copy Download .nbib Format: NLM
Qualitative Evaluation of a Community-Based Physical Activity and Yoga Program for Men Living With Prostate Cancer: Survivor Perspectives.

Global advances in health and medicine

Culos-Reed SN, Dew M, Shank J, Langelier DM, McDonough M.
PMID: 31024755
Glob Adv Health Med. 2019 Apr 17;8:2164956119837487. doi: 10.1177/2164956119837487. eCollection 2019.

PURPOSE: Physical activity (PA) programs for prostate cancer survivors have positive effects on many aspects of health-related quality of life. Translating this research into sustainable community-based settings is necessary to ensure access to programs for survivors. This study examines...

Cite
Culos-Reed SN, Dew M, Shank J, et al. Qualitative Evaluation of a Community-Based Physical Activity and Yoga Program for Men Living With Prostate Cancer: Survivor Perspectives. Glob Adv Health Med. 2019;8:2164956119837487doi: 10.1177/2164956119837487.
Culos-Reed, S. N., Dew, M., Shank, J., Langelier, D. M., & McDonough, M. (2019). Qualitative Evaluation of a Community-Based Physical Activity and Yoga Program for Men Living With Prostate Cancer: Survivor Perspectives. Global advances in health and medicine, 82164956119837487. https://doi.org/10.1177/2164956119837487
Culos-Reed, S N, et al. "Qualitative Evaluation of a Community-Based Physical Activity and Yoga Program for Men Living With Prostate Cancer: Survivor Perspectives." Global advances in health and medicine vol. 8 (2019): 2164956119837487. doi: https://doi.org/10.1177/2164956119837487
Culos-Reed SN, Dew M, Shank J, Langelier DM, McDonough M. Qualitative Evaluation of a Community-Based Physical Activity and Yoga Program for Men Living With Prostate Cancer: Survivor Perspectives. Glob Adv Health Med. 2019 Apr 17;8:2164956119837487. doi: 10.1177/2164956119837487. eCollection 2019. PMID: 31024755; PMCID: PMC6472160.
Copy Download .nbib Format: NLM
Draft Genome Sequence of an Extensively Drug-Resistant Salmonella enterica Serovar Typhi Strain from a Returned Traveler from Pakistan.

Microbiology resource announcements

Hao S, Veuthey T, Caldera S, Serpa PH, Haller B, Tan M, Neff N, Madera S, Langelier C.
PMID: 32732230
Microbiol Resour Announc. 2020 Jul 30;9(31). doi: 10.1128/MRA.00427-20.

We report a draft genome sequence of extensively drug-resistant (XDR)

Cite
Hao S, Veuthey T, Caldera S, et al. Draft Genome Sequence of an Extensively Drug-Resistant Salmonella enterica Serovar Typhi Strain from a Returned Traveler from Pakistan. Microbiol Resour Announc. 2020;9(31)doi: 10.1128/MRA.00427-20.
Hao, S., Veuthey, T., Caldera, S., Serpa, P. H., Haller, B., Tan, M., Neff, N., Madera, S., & Langelier, C. (2020). Draft Genome Sequence of an Extensively Drug-Resistant Salmonella enterica Serovar Typhi Strain from a Returned Traveler from Pakistan. Microbiology resource announcements, 9(31), . https://doi.org/10.1128/MRA.00427-20
Hao, Samantha, et al. "Draft Genome Sequence of an Extensively Drug-Resistant Salmonella enterica Serovar Typhi Strain from a Returned Traveler from Pakistan." Microbiology resource announcements vol. 9,31 (2020). doi: https://doi.org/10.1128/MRA.00427-20
Hao S, Veuthey T, Caldera S, Serpa PH, Haller B, Tan M, Neff N, Madera S, Langelier C. Draft Genome Sequence of an Extensively Drug-Resistant Salmonella enterica Serovar Typhi Strain from a Returned Traveler from Pakistan. Microbiol Resour Announc. 2020 Jul 30;9(31). doi: 10.1128/MRA.00427-20. PMID: 32732230; PMCID: PMC7393959.
Copy Download .nbib Format: NLM
Impaired antibacterial immune signaling and changes in the lung microbiome precede secondary bacterial pneumonia in COVID-19.

medRxiv : the preprint server for health sciences

Tsitsiklis A, Zha BS, Byrne A, Devoe C, Levan S, Rackaityte E, Sunshine S, Mick E, Ghale R, Jauregui A, Sarma A, Neff N, Serpa PH, Deiss TJ, Kistler A, Carrillo S, Ansel KM, Leligdowicz A, Christenson S, Jones N, Wu B, Darmanis S, Matthay MA, Lynch SV, DeRisi JL, Hendrickson CM, Kangelaris KN, Krummel MF, Woodruff PG, Erle DJ, Rosenberg O, Calfee CS, Langelier CR.
PMID: 33791731
medRxiv. 2021 Mar 26; doi: 10.1101/2021.03.23.21253487.

Secondary bacterial infections, including ventilator-associated pneumonia (VAP), lead to worse clinical outcomes and increased mortality following viral respiratory infections. Critically ill patients with coronavirus disease 2019 (COVID-19) face an elevated risk of VAP, although susceptibility varies widely. Because mechanisms...

Cite
Tsitsiklis A, Zha BS, Byrne A, et al. Impaired antibacterial immune signaling and changes in the lung microbiome precede secondary bacterial pneumonia in COVID-19. medRxiv. 2021;doi: 10.1101/2021.03.23.21253487.
Tsitsiklis, A., Zha, B. S., Byrne, A., Devoe, C., Levan, S., Rackaityte, E., Sunshine, S., Mick, E., Ghale, R., Jauregui, A., Sarma, A., Neff, N., Serpa, P. H., Deiss, T. J., Kistler, A., Carrillo, S., Ansel, K. M., Leligdowicz, A., Christenson, S., Jones, N., Wu, B., Darmanis, S., Matthay, M. A., Lynch, S. V., DeRisi, J. L., Hendrickson, C. M., Kangelaris, K. N., Krummel, M. F., Woodruff, P. G., Erle, D. J., Rosenberg, O., Calfee, C. S., & Langelier, C. R. (2021). Impaired antibacterial immune signaling and changes in the lung microbiome precede secondary bacterial pneumonia in COVID-19. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.03.23.21253487
Tsitsiklis, Alexandra, et al. "Impaired antibacterial immune signaling and changes in the lung microbiome precede secondary bacterial pneumonia in COVID-19." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.03.23.21253487
Tsitsiklis A, Zha BS, Byrne A, Devoe C, Levan S, Rackaityte E, Sunshine S, Mick E, Ghale R, Jauregui A, Sarma A, Neff N, Serpa PH, Deiss TJ, Kistler A, Carrillo S, Ansel KM, Leligdowicz A, Christenson S, Jones N, Wu B, Darmanis S, Matthay MA, Lynch SV, DeRisi JL, Hendrickson CM, Kangelaris KN, Krummel MF, Woodruff PG, Erle DJ, Rosenberg O, Calfee CS, Langelier CR. Impaired antibacterial immune signaling and changes in the lung microbiome precede secondary bacterial pneumonia in COVID-19. medRxiv. 2021 Mar 26; doi: 10.1101/2021.03.23.21253487. PMID: 33791731; PMCID: PMC8010763.
Copy Download .nbib Format: NLM
Intestinal Infection Is Associated With Impaired Lung Innate Immunity to Secondary Respiratory Infection.

Open forum infectious diseases

Trivedi S, Grossmann AH, Jensen O, Cody MJ, Wahlig TA, Hayakawa Serpa P, Langelier C, Warren KJ, Yost CC, Leung DT.
PMID: 34189172
Open Forum Infect Dis. 2021 May 07;8(6):ofab237. doi: 10.1093/ofid/ofab237. eCollection 2021 Jun.

BACKGROUND: Pneumonia and diarrhea are among the leading causes of death worldwide, and epidemiological studies have demonstrated that diarrhea is associated with an increased risk of subsequent pneumonia. Our aim was to determine the impact of intestinal infection on...

Cite
Trivedi S, Grossmann AH, Jensen O, et al. Intestinal Infection Is Associated With Impaired Lung Innate Immunity to Secondary Respiratory Infection. Open Forum Infect Dis. 2021;8(6):ofab237doi: 10.1093/ofid/ofab237.
Trivedi, S., Grossmann, A. H., Jensen, O., Cody, M. J., Wahlig, T. A., Hayakawa Serpa, P., Langelier, C., Warren, K. J., Yost, C. C., & Leung, D. T. (2021). Intestinal Infection Is Associated With Impaired Lung Innate Immunity to Secondary Respiratory Infection. Open forum infectious diseases, 8(6), ofab237. https://doi.org/10.1093/ofid/ofab237
Trivedi, Shubhanshi, et al. "Intestinal Infection Is Associated With Impaired Lung Innate Immunity to Secondary Respiratory Infection." Open forum infectious diseases vol. 8,6 (2021): ofab237. doi: https://doi.org/10.1093/ofid/ofab237
Trivedi S, Grossmann AH, Jensen O, Cody MJ, Wahlig TA, Hayakawa Serpa P, Langelier C, Warren KJ, Yost CC, Leung DT. Intestinal Infection Is Associated With Impaired Lung Innate Immunity to Secondary Respiratory Infection. Open Forum Infect Dis. 2021 May 07;8(6):ofab237. doi: 10.1093/ofid/ofab237. eCollection 2021 Jun. PMID: 34189172; PMCID: PMC8231398.
Copy Download .nbib Format: NLM
The sputum transcriptome better predicts COPD exacerbations after the withdrawal of inhaled corticosteroids than sputum eosinophils.

ERJ open research

Ditz B, Sarma A, Kerstjens HAM, Liesker JJW, Bathoorn E, Vonk JM, Bernal V, Horvatovich P, Guryev V, Caldera S, Langelier C, Faiz A, Christenson SA, van den Berge M.
PMID: 34235210
ERJ Open Res. 2021 Jul 05;7(3). doi: 10.1183/23120541.00097-2021. eCollection 2021 Jul.

INTRODUCTION: Continuing inhaled corticosteroid (ICS) use does not benefit all patients with COPD, yet it is difficult to determine which patients may safely sustain ICS withdrawal. Although eosinophil levels can facilitate this decision, better biomarkers could improve personalised treatment...

Cite
Ditz B, Sarma A, Kerstjens HAM, et al. The sputum transcriptome better predicts COPD exacerbations after the withdrawal of inhaled corticosteroids than sputum eosinophils. ERJ Open Res. 2021;7(3)doi: 10.1183/23120541.00097-2021.
Ditz, B., Sarma, A., Kerstjens, H. A. M., Liesker, J. J. W., Bathoorn, E., Vonk, J. M., Bernal, V., Horvatovich, P., Guryev, V., Caldera, S., Langelier, C., Faiz, A., Christenson, S. A., & van den Berge, M. (2021). The sputum transcriptome better predicts COPD exacerbations after the withdrawal of inhaled corticosteroids than sputum eosinophils. ERJ open research, 7(3), . https://doi.org/10.1183/23120541.00097-2021
Ditz, Benedikt, et al. "The sputum transcriptome better predicts COPD exacerbations after the withdrawal of inhaled corticosteroids than sputum eosinophils." ERJ open research vol. 7,3 (2021). doi: https://doi.org/10.1183/23120541.00097-2021
Ditz B, Sarma A, Kerstjens HAM, Liesker JJW, Bathoorn E, Vonk JM, Bernal V, Horvatovich P, Guryev V, Caldera S, Langelier C, Faiz A, Christenson SA, van den Berge M. The sputum transcriptome better predicts COPD exacerbations after the withdrawal of inhaled corticosteroids than sputum eosinophils. ERJ Open Res. 2021 Jul 05;7(3). doi: 10.1183/23120541.00097-2021. eCollection 2021 Jul. PMID: 34235210; PMCID: PMC8255541.
Copy Download .nbib Format: NLM
Cerebrospinal Fluid Pterins, Pterin-Dependent Neurotransmitters, and Mortality in Pediatric Cerebral Malaria.

The Journal of infectious diseases

Rubach MP, Mukemba JP, Florence SM, Lopansri BK, Hyland K, Simmons RA, Langelier C, Nakielny S, DeRisi JL, Yeo TW, Anstey NM, Weinberg JB, Mwaikambo ED, Granger DL.
PMID: 33617646
J Infect Dis. 2021 Oct 28;224(8):1432-1441. doi: 10.1093/infdis/jiab086.

BACKGROUND: Cerebral malaria (CM) pathogenesis remains incompletely understood. Having shown low systemic levels of tetrahydrobiopterin (BH4), an enzymatic cofactor for neurotransmitter synthesis, we hypothesized that BH4 and BH4-dependent neurotransmitters would likewise be low in cerebrospinal fluid (CSF) in CM.METHODS:...

Cite
Rubach MP, Mukemba JP, Florence SM, et al. Cerebrospinal Fluid Pterins, Pterin-Dependent Neurotransmitters, and Mortality in Pediatric Cerebral Malaria. J Infect Dis. 2021;224(8):1432-1441doi: 10.1093/infdis/jiab086.
Rubach, M. P., Mukemba, J. P., Florence, S. M., Lopansri, B. K., Hyland, K., Simmons, R. A., Langelier, C., Nakielny, S., DeRisi, J. L., Yeo, T. W., Anstey, N. M., Weinberg, J. B., Mwaikambo, E. D., & Granger, D. L. (2021). Cerebrospinal Fluid Pterins, Pterin-Dependent Neurotransmitters, and Mortality in Pediatric Cerebral Malaria. The Journal of infectious diseases, 224(8), 1432-1441. https://doi.org/10.1093/infdis/jiab086
Rubach, Matthew P, et al. "Cerebrospinal Fluid Pterins, Pterin-Dependent Neurotransmitters, and Mortality in Pediatric Cerebral Malaria." The Journal of infectious diseases vol. 224,8 (2021): 1432-1441. doi: https://doi.org/10.1093/infdis/jiab086
Rubach MP, Mukemba JP, Florence SM, Lopansri BK, Hyland K, Simmons RA, Langelier C, Nakielny S, DeRisi JL, Yeo TW, Anstey NM, Weinberg JB, Mwaikambo ED, Granger DL. Cerebrospinal Fluid Pterins, Pterin-Dependent Neurotransmitters, and Mortality in Pediatric Cerebral Malaria. J Infect Dis. 2021 Oct 28;224(8):1432-1441. doi: 10.1093/infdis/jiab086. PMID: 33617646; PMCID: PMC8682765.
Copy Download .nbib Format: NLM
Global Absence and Targeting of Protective Immune States in Severe COVID-19.

Research square

Combes AJ, Courau T, Kuhn NF, Hu KH, Ray A, Chen WS, Cleary SJ, Chew NW, Kushnoor D, Reeder GC, Shen A, Tsui J, Hiam-Galvez KJ, Muñoz-Sandoval P, Zhu WS, Lee DS, Sun Y, You R, Magnen M, Rodriguez L, Leligdowicz A, Zamecnik CR, Loudermilk RP, Wilson MR, Ye CJ, Fragiadakis GK, Looney MR, Chan V, Ward A, Carrillo S, Matthay M, Erle DJ, Woodruff PG, Langelier C, Kangelaris K, Hendrickson CM, Calfee C, Rao AA, Krummel MF.
PMID: 33140041
Res Sq. 2020 Oct 28; doi: 10.21203/rs.3.rs-97042/v1.

While SARS-CoV-2 infection has pleiotropic and systemic effects in some patients, many others experience milder symptoms. We sought a holistic understanding of the severe/mild distinction in COVID-19 pathology, and its origins. We performed a wholeblood preserving single-cell analysis protocol...

Cite
Combes AJ, Courau T, Kuhn NF, et al. Global Absence and Targeting of Protective Immune States in Severe COVID-19. Res Sq. 2020;doi: 10.21203/rs.3.rs-97042/v1.
Combes, A. J., Courau, T., Kuhn, N. F., Hu, K. H., Ray, A., Chen, W. S., Cleary, S. J., Chew, N. W., Kushnoor, D., Reeder, G. C., Shen, A., Tsui, J., Hiam-Galvez, K. J., Muñoz-Sandoval, P., Zhu, W. S., Lee, D. S., Sun, Y., You, R., Magnen, M., Rodriguez, L., Leligdowicz, A., Zamecnik, C. R., Loudermilk, R. P., Wilson, M. R., Ye, C. J., Fragiadakis, G. K., Looney, M. R., Chan, V., Ward, A., Carrillo, S., Matthay, M., Erle, D. J., Woodruff, P. G., Langelier, C., Kangelaris, K., Hendrickson, C. M., Calfee, C., Rao, A. A., & Krummel, M. F. (2020). Global Absence and Targeting of Protective Immune States in Severe COVID-19. Research square, . https://doi.org/10.21203/rs.3.rs-97042/v1
Combes, Alexis J, et al. "Global Absence and Targeting of Protective Immune States in Severe COVID-19." Research square vol. (2020). doi: https://doi.org/10.21203/rs.3.rs-97042/v1
Combes AJ, Courau T, Kuhn NF, Hu KH, Ray A, Chen WS, Cleary SJ, Chew NW, Kushnoor D, Reeder GC, Shen A, Tsui J, Hiam-Galvez KJ, Muñoz-Sandoval P, Zhu WS, Lee DS, Sun Y, You R, Magnen M, Rodriguez L, Leligdowicz A, Zamecnik CR, Loudermilk RP, Wilson MR, Ye CJ, Fragiadakis GK, Looney MR, Chan V, Ward A, Carrillo S, Matthay M, Erle DJ, Woodruff PG, Langelier C, Kangelaris K, Hendrickson CM, Calfee C, Rao AA, Krummel MF. Global Absence and Targeting of Protective Immune States in Severe COVID-19. Res Sq. 2020 Oct 28; doi: 10.21203/rs.3.rs-97042/v1. PMID: 33140041; PMCID: PMC7605560.
Copy Download .nbib Format: NLM
Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01.

EClinicalMedicine

Weiner J, Suwalski P, Holtgrewe M, Rakitko A, Thibeault C, Müller M, Patriki D, Quedenau C, Krüger U, Ilinsky V, Popov I, Balnis J, Jaitovich A, Helbig ET, Lippert LJ, Stubbemann P, Real LM, Macías J, Pineda JA, Fernandez-Fuertes M, Wang X, Karadeniz Z, Saccomanno J, Doehn JM, Hübner RH, Hinzmann B, Salvo M, Blueher A, Siemann S, Jurisic S, Beer JH, Rutishauser J, Wiggli B, Schmid H, Danninger K, Binder R, Corman VM, Mühlemann B, Arjun Arkal R, Fragiadakis GK, Mick E, Comet C, Calfee CS, Erle DJ, Hendrickson CM, Kangelaris KN, Krummel MF, Woodruff PG, Langelier CR, Venkataramani U, García F, Zyla J, Drosten C, Alice B, Jones TC, Suttorp N, Witzenrath M, Hippenstiel S, Zemojtel T, Skurk C, Poller W, Borodina T, Pa-Covid SG, Ripke S, Sander LE, Beule D, Landmesser U, Guettouche T, Kurth F, Heidecker B.
PMID: 34490415
EClinicalMedicine. 2021 Oct;40:101099. doi: 10.1016/j.eclinm.2021.101099. Epub 2021 Sep 02.

BACKGROUND: Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, there has been increasing urgency to identify pathophysiological characteristics leading to severe clinical course in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Human leukocyte antigen...

Cite
Weiner J, Suwalski P, Holtgrewe M, et al. Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01. EClinicalMedicine. 2021;40:101099doi: 10.1016/j.eclinm.2021.101099.
Weiner, J., Suwalski, P., Holtgrewe, M., Rakitko, A., Thibeault, C., Müller, M., Patriki, D., Quedenau, C., Krüger, U., Ilinsky, V., Popov, I., Balnis, J., Jaitovich, A., Helbig, E. T., Lippert, L. J., Stubbemann, P., Real, L. M., Macías, J., Pineda, J. A., Fernandez-Fuertes, M., Wang, X., Karadeniz, Z., Saccomanno, J., Doehn, J. M., Hübner, R. H., Hinzmann, B., Salvo, M., Blueher, A., Siemann, S., Jurisic, S., Beer, J. H., Rutishauser, J., Wiggli, B., Schmid, H., Danninger, K., Binder, R., Corman, V. M., Mühlemann, B., Arjun Arkal, R., Fragiadakis, G. K., Mick, E., Comet, C., Calfee, C. S., Erle, D. J., Hendrickson, C. M., Kangelaris, K. N., Krummel, M. F., Woodruff, P. G., Langelier, C. R., Venkataramani, U., García, F., Zyla, J., Drosten, C., Alice, B., Jones, T. C., Suttorp, N., Witzenrath, M., Hippenstiel, S., Zemojtel, T., Skurk, C., Poller, W., Borodina, T., Pa-Covid, S. G., Ripke, S., Sander, L. E., Beule, D., Landmesser, U., Guettouche, T., Kurth, F., & Heidecker, B. (2021). Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01. EClinicalMedicine, 40101099. https://doi.org/10.1016/j.eclinm.2021.101099
Weiner, January, et al. "Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01." EClinicalMedicine vol. 40 (2021): 101099. doi: https://doi.org/10.1016/j.eclinm.2021.101099
Weiner J, Suwalski P, Holtgrewe M, Rakitko A, Thibeault C, Müller M, Patriki D, Quedenau C, Krüger U, Ilinsky V, Popov I, Balnis J, Jaitovich A, Helbig ET, Lippert LJ, Stubbemann P, Real LM, Macías J, Pineda JA, Fernandez-Fuertes M, Wang X, Karadeniz Z, Saccomanno J, Doehn JM, Hübner RH, Hinzmann B, Salvo M, Blueher A, Siemann S, Jurisic S, Beer JH, Rutishauser J, Wiggli B, Schmid H, Danninger K, Binder R, Corman VM, Mühlemann B, Arjun Arkal R, Fragiadakis GK, Mick E, Comet C, Calfee CS, Erle DJ, Hendrickson CM, Kangelaris KN, Krummel MF, Woodruff PG, Langelier CR, Venkataramani U, García F, Zyla J, Drosten C, Alice B, Jones TC, Suttorp N, Witzenrath M, Hippenstiel S, Zemojtel T, Skurk C, Poller W, Borodina T, Pa-Covid SG, Ripke S, Sander LE, Beule D, Landmesser U, Guettouche T, Kurth F, Heidecker B. Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01. EClinicalMedicine. 2021 Oct;40:101099. doi: 10.1016/j.eclinm.2021.101099. Epub 2021 Sep 02. PMID: 34490415; PMCID: PMC8410317.
Copy Download .nbib Format: NLM
Teledentistry: Increasing utilisation of oral-health services for children in rural areas.

Journal of telemedicine and telecare

Surdu S, Langelier M.
PMID: 33070687
J Telemed Telecare. 2020 Oct 18;1357633X20965425. doi: 10.1177/1357633X20965425. Epub 2020 Oct 18.

INTRODUCTION: The objective of this study was to evaluate factors influencing utilisation of follow-up oral-health services in general dentistry clinics among children subsequent to a teledentistry consultation and treatment with a paediatric dental specialist.METHODS: Conducted in 2017, the study...

Cite
Surdu S, Langelier M. Teledentistry: Increasing utilisation of oral-health services for children in rural areas. J Telemed Telecare. 2020;1357633X20965425doi: 10.1177/1357633X20965425.
Surdu, S., & Langelier, M. (2020). Teledentistry: Increasing utilisation of oral-health services for children in rural areas. Journal of telemedicine and telecare, 1357633X20965425. https://doi.org/10.1177/1357633X20965425
Surdu, Simona, and Langelier, Margaret. "Teledentistry: Increasing utilisation of oral-health services for children in rural areas." Journal of telemedicine and telecare vol. (2020): 1357633X20965425. doi: https://doi.org/10.1177/1357633X20965425
Surdu S, Langelier M. Teledentistry: Increasing utilisation of oral-health services for children in rural areas. J Telemed Telecare. 2020 Oct 18;1357633X20965425. doi: 10.1177/1357633X20965425. Epub 2020 Oct 18. PMID: 33070687.
Copy Download .nbib Format: NLM
Fever, abdominal pain, serositis, arthralgia, hearing loss, proteinuria, and a family history: Muckle Wells syndrome.

Lancet (London, England)

Al-Matar SH, Sairam C, Roussel L, Langelier MJ, Vinh DC.
PMID: 34863351
Lancet. 2021 Dec 04;398(10316):2101. doi: 10.1016/S0140-6736(21)02139-5.

No abstract available.

Cite
Al-Matar SH, Sairam C, Roussel L, et al. Fever, abdominal pain, serositis, arthralgia, hearing loss, proteinuria, and a family history: Muckle Wells syndrome. Lancet. 2021;398(10316):2101doi: 10.1016/S0140-6736(21)02139-5.
Al-Matar, S. H., Sairam, C., Roussel, L., Langelier, M. J., & Vinh, D. C. (2021). Fever, abdominal pain, serositis, arthralgia, hearing loss, proteinuria, and a family history: Muckle Wells syndrome. Lancet (London, England), 398(10316), 2101. https://doi.org/10.1016/S0140-6736(21)02139-5
Al-Matar, Shahad H, et al. "Fever, abdominal pain, serositis, arthralgia, hearing loss, proteinuria, and a family history: Muckle Wells syndrome." Lancet (London, England) vol. 398,10316 (2021): 2101. doi: https://doi.org/10.1016/S0140-6736(21)02139-5
Al-Matar SH, Sairam C, Roussel L, Langelier MJ, Vinh DC. Fever, abdominal pain, serositis, arthralgia, hearing loss, proteinuria, and a family history: Muckle Wells syndrome. Lancet. 2021 Dec 04;398(10316):2101. doi: 10.1016/S0140-6736(21)02139-5. PMID: 34863351.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 66 entries